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total insert length, 700bp, of the
resulting bands. (KRAS is only 600 bp)
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Conclusion and learnings

The overexpression vector for the gene encoding
for KRAS contain the noncanonical mutation R164L

was successfully cloned. The resulting clones shall now be utilized through various functional characterization
assays. Various Molecular Biological concepts such as cancer mutations and MolBio techniques were learned
throughout this study.

